Correlation Between Apellis Pharmaceuticals and Immunic
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Immunic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Immunic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Immunic, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Immunic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Immunic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Immunic.
Diversification Opportunities for Apellis Pharmaceuticals and Immunic
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Apellis and Immunic is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Immunic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunic and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Immunic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunic has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Immunic go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Immunic
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 0.73 times more return on investment than Immunic. However, Apellis Pharmaceuticals is 1.36 times less risky than Immunic. It trades about -0.01 of its potential returns per unit of risk. Immunic is currently generating about -0.09 per unit of risk. If you would invest 3,553 in Apellis Pharmaceuticals on September 17, 2024 and sell it today you would lose (186.00) from holding Apellis Pharmaceuticals or give up 5.24% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Apellis Pharmaceuticals vs. Immunic
Performance |
Timeline |
Apellis Pharmaceuticals |
Immunic |
Apellis Pharmaceuticals and Immunic Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Apellis Pharmaceuticals and Immunic
The main advantage of trading using opposite Apellis Pharmaceuticals and Immunic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Immunic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunic will offset losses from the drop in Immunic's long position.Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Immunic vs. Generation Bio Co | Immunic vs. Kronos Bio | Immunic vs. Erasca Inc | Immunic vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |